Article Versions Notes

Seidensticker M, Steffen IG, Bargellini I, Berg T, Benito A, Gebauer B, Iezzi R, Loewe C, Karçaaltincaba M, Pech M, et al. Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort. Current Oncology. 2022; 29(2):565-577. https://doi.org/10.3390/curroncol29020051

Seidensticker, Max, Ingo G. Steffen, Irene Bargellini, Thomas Berg, Alberto Benito, Bernhard Gebauer, Roberto Iezzi, Christian Loewe, Musturay Karçaaltincaba, Maciej Pech, and et al. 2022. "Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort" Current Oncology 29, no. 2: 565-577. https://doi.org/10.3390/curroncol29020051

Seidensticker, M., Steffen, I. G., Bargellini, I., Berg, T., Benito, A., Gebauer, B., Iezzi, R., Loewe, C., Karçaaltincaba, M., Pech, M., Sengel, C., van Delden, O., Vandecaveye, V., Zech, C. J., & Ricke, J. (2022). Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort. Current Oncology, 29(2), 565-577. https://doi.org/10.3390/curroncol29020051